Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ostendorf, T.
Right arrow Articles by Floege, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ostendorf, T.
Right arrow Articles by Floege, J.
J Am Soc Nephrol 13:658-667, 2002
© 2002 American Society of Nephrology

The Effects of Platelet-Derived Growth Factor Antagonism in Experimental Glomerulonephritis Are Independent of the Transforming Growth Factor–ß System

Tammo Ostendorf*, Uta Kunter*, Claudia van Roeyen*, Steven Dooley{dagger}, Nebojsa Janjic{ddagger}, Judy Ruckman§, Frank Eitner and Jürgen Floege*

*Division of Nephrology and Immunology and {dagger}Institute of Clinical Chemistry and Pathobiochemistry, University of Aachen, Aachen, Germany; {ddagger}Replidyne, Inc., Denver, Colorado; and §Gilead Sciences, Inc., Boulder, Colorado.

Correspondence to Dr. Jürgen Floege, University of Aachen, Medizinische Klinik II, Klinikum der RWTH, Pauwelsstrasse 30, 52074 Aachen, Germany. Phone: 49-241-8089530; Fax: 49-241-8888446; E-mail: juergen.floege{at}post.rwth-aachen.de

ABSTRACT. Platelet-derived growth factor B-chain (PDGF-B)– and transforming growth factor beta (TGF-ß)–mediated accumulation of extracellular matrix proteins contributes to many progressive renal diseases. In vivo, specific antagonism of either PDGF-B or TGF-ß in experimental mesangioproliferative glomerulonephritis resulted in an almost complete inhibition of matrix protein accumulation, which suggests an interaction between signaling pathways of these two growth factors. Because nothing is known on the nature of this possible interaction, PDGF-B was antagonized in the rat anti–Thy 1.1 model of glomerulonephritis by use of specific aptamers and its effects on the TGF-ß system were investigated. Antagonism of PDGF-B led to a significant reduction of glomerular matrix accumulation compared with scrambled aptamer-treated nephritic controls. PDGF-B antagonism had no effect on the overexpression of glomerular TGF-ß mRNA, TGF-ß protein, or the expression of TGF-ß receptor type I and II mRNA. By immunohistology, it was possible to detect overexpression of the cytoplasmic TGF-ß signaling molecules Smad2 (agonistic) and Smad7 (antagonistic) in glomeruli of nephritic control rats which peaked on day 7 after disease induction, i.e., the peak of mesangial cell proliferation in this model. However, immunohistology and Western blot analysis again revealed no difference in the glomerular expression of both Smad proteins between PDGF-B antagonized and nonantagonized nephritic animals. In addition, no difference in the glomerular expression of phosphorylated Smad2 (P-Smad2) was detected between the differently treated nephritic groups. These observations suggest that the effects of PDGF-B antagonism are independent of TGF-ß in mesangioproliferative glomerulonephritides.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
J. Floege, F. Eitner, and C. E. Alpers
A New Look at Platelet-Derived Growth Factor in Renal Disease
J. Am. Soc. Nephrol., January 1, 2008; 19(1): 12 - 23.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. Boor, A. Konieczny, L. Villa, A.-L. Schult, E. Bucher, S. Rong, U. Kunter, C. R.C. van Roeyen, T. Polakowski, H. Hawlisch, et al.
Complement C5 Mediates Experimental Tubulointerstitial Fibrosis
J. Am. Soc. Nephrol., May 1, 2007; 18(5): 1508 - 1515.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
M. C. Banas, W. T. Parks, K. L. Hudkins, B. Banas, M. Holdren, M. Iyoda, T. A. Wietecha, J. Kowalewska, G. Liu, and C. E. Alpers
Localization of TGF-{beta} Signaling Intermediates Smad2, 3, 4, and 7 in Developing and Mature Human and Mouse Kidney
J. Histochem. Cytochem., March 1, 2007; 55(3): 275 - 285.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. R.C. van Roeyen, F. Eitner, S. Martinkus, S. R. Thieltges, T. Ostendorf, D. Bokemeyer, B. Luscher, J. M. Luscher-Firzlaff, J. Floege, and P. R. Mertens
Y-Box Protein 1 Mediates PDGF-B Effects in Mesangioproliferative Glomerular Disease
J. Am. Soc. Nephrol., October 1, 2005; 16(10): 2985 - 2996.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Rodgers, B. McMahon, D. Mitchell, D. Sadlier, and C. Godson
Lipoxin A4 Modifies Platelet-Derived Growth Factor-Induced Profibrotic Gene Expression in Human Renal Mesangial Cells
Am. J. Pathol., September 1, 2005; 167(3): 683 - 694.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Lassila, K. Jandeleit-Dahm, K. K. Seah, C. M. Smith, A. C. Calkin, T. J. Allen, and M. E. Cooper
Imatinib Attenuates Diabetic Nephropathy in Apolipoprotein E-Knockout Mice
J. Am. Soc. Nephrol., February 1, 2005; 16(2): 363 - 373.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Fukasawa, T. Yamamoto, A. Togawa, N. Ohashi, Y. Fujigaki, T. Oda, C. Uchida, K. Kitagawa, T. Hattori, S. Suzuki, et al.
Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice
PNAS, June 8, 2004; 101(23): 8687 - 8692.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. Ma, T. Matsusaka, H. Yang, H. Kawachi, F. Shimizu, Y. Isaka, E. Imai, V. Kon, and I. Ichikawa
Local Actions of Endogenous Angiotensin II in Injured Glomeruli
J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1268 - 1276.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. Ostendorf, C. R.C. van Roeyen, J. D. Peterson, U. Kunter, F. Eitner, A. J. Hamad, G. Chan, X.-C. Jia, J. Macaluso, G. Gazit-Bornstein, et al.
A Fully Human Monoclonal Antibody (CR002) Identifies PDGF-D as a Novel Mediator of Mesangioproliferative Glomerulonephritis
J. Am. Soc. Nephrol., September 1, 2003; 14(9): 2237 - 2247.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. A. Aben, D. A. Hoogervorst, L. C. Paul, M. C. Borrias, N. A. Noble, W. A. Border, J. A. Bruijn, and E. de Heer
Genes Expressed by the Kidney, but Not by Bone Marrow-Derived Cells, Underlie the Genetic Predisposition to Progressive Glomerulosclerosis after Mesangial Injury
J. Am. Soc. Nephrol., September 1, 2003; 14(9): 2264 - 2270.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. R. White, S. Shan, C. P. Rusconi, G. Shetty, M. W. Dewhirst, C. D. Kontos, and B. A. Sullenger
Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2
PNAS, April 29, 2003; 100(9): 5028 - 5033.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP